Dr Reddys Labs Launches Generic Uloric Tablets
Dr Reddy'S Laboratories Ltd Announced The Launch Of Febuxostat Tablets, A Therapeutic Equivalent Generic Version Of Uloric (Febuxostat) Tablets Approved By The Us Food And Drug Administration (Fda).The Uloric Brand And Generic Had Us Sales Of Approximately Us$ 108 Million Mat For The Most Recent Twelve Months Ending In October 2020, According To Iqvia Health.Dr Reddy'S Febuxostat Tablets Are Available In 40 Mg And 80 Mg Strengths In Bottle Count Sizes Of 30 Tablets
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
